Table 3.
Drug-resistance pattern
| Primary cases (n = 51) | Presumptive drug-resistance cases (n = 8) | Overall (n = 59) | |
|---|---|---|---|
| Resistance cases | 13/51 (25.49%) | 3/8 (37.5%) | 16/59 (27.12%) |
| Mono-drug resistance | 3 | 1 | 4 |
| Only INH resistance = 3 | Only INH resistance = 1 | Only INH resistance = 4 | |
| Only RIF resistance = 0 | Only RIF resistance = 0 | Only RIF resistance = 0 | |
| Poly-drug resistance | 10 | 2 | 12 |
| INH + RIF (MDR-TB) = 3 | INH + RIF (MDR-TB) = 2 | INH + RIF (MDR-TB) = 5 | |
| RIF + FQ = 1 | INH + RIF + FQ (Pre-XDR TB) = 0 | RIF + FQ = 1 | |
| FQ + Lz = 1 | INH + RIF + SLID (Pre-XDR TB) = 0 | FQ + Lz = 1 | |
| SLID (Km, Cap, Ak) = 1 | INH + RIF + FQ + SLID (XDR TB) = 0 | SLID (Km, Cap, Ak) = 1 | |
| FQ (Mox, Lev) = 1 | FQ (Mox, Lev) = 1 | ||
| INH + RIF + FQ (Pre-XDR TB) = 3 | INH + RIF + FQ (Pre-XDR TB) = 3 | ||
| INH + RIF + SLID (Pre-XDR TB) = 0 | INH + RIF + SLID (Pre-XDR TB) = 0 | ||
| INH + RIF + FQ + SLID (XDR TB) = 0 | INH + RIF + FQ + SLID (XDR TB) = 0 |